The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LI.ak

Cardiotoxicity

Publications

Ewer MS, Ewer SM

Cardiotoxicity of anticancer treatments.

Nature reviews. Cardiology 2015 Sep;12;547-58 — 2015 Sep — 547-58

Sadurska E

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors.

Pediatric cardiology 2015 Aug;36;1112-9 — 2015 Aug — 1112-9

Bayram C, Çetin ?, Tavil B, Yarali N, Ekici F, Is?k P, Tunc B

Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline.

Pediatric cardiology 2015 Apr;36;862-6 — 2015 Apr — 862-6

Roodpeyma S, Moussavi F, Kamali Z

Late cardiotoxic effects of anthracycline chemotherapy in childhood malignancies.

JPMA. The Journal of the Pakistan Medical Association 2008 Dec;58;683-7 — 2008 Dec — 683-7